NO.1 BOEHRINGER INGELHEIM - pharma field · pharma company in the UK, it is a truly amazing place...
1
Pf EMPLOYER OF CHOICE 2012 THERAPEUTIC SPECIALITIES Cardiovascular disease, respiratory disease (COPD), diabetes, yypertension, Parkinson’s disease, HIV. KEY PRODUCTS Pradaxa, Spiriva, Trajenta, Micardis and Mirapexin, Viramune. PIPELINE DEVELOPMENTS Diabetes, cardiometabolic diseases, central nervous system diseases, immunology, infectious diseases, oncology, respiratory. NUMBER OF OFFICES GLOBALLY 145 ANNUAL GLOBAL REVENUES EUR 12,586 million. CONTACT DETAILS Ellesfield Avenue Bracknell Berkshire RG12 8YS UK WEBSITE: www.boehringer-ingelheim. co.uk UK CAREERS SITE: www.boehringer-ingelheim. co.uk/careers/careers.html HR CONTACT: Tanya Mohamoodally. NO.1 BOEHRINGER INGELHEIM ACHIEVEMENTS IN 2011/12 Celebrated 50 years of being in the UK in May. Winners in the career representative and overall primary care category at the 2012 Pharma Times representative of the year awards. Again voted as one of the best companies to work for in the 2012 Sunday Times Top 100 ‘Best Companies’ survey rising up to 62nd place. OVERVIEW We are a privately owned German company with over 42,000 employees worldwide and a global vision of “Value through Innovation”. Our mission is to improve the health and wellbeing of people and animals through being part of an independent, innovative, research and development driven company. STRENGTHS Our culture is one of transparency and respect for the individual; we try to empower people and listen to their ideas. We also emphasise personal development and improvement, backed by excellent training. INITIATIVES IN 2012/13 “Painting BI’s Future” a strategic review in response to the changing environment. Recommendations are now being further developed through “Implementing BI’s future” with eight cross-divisional teams exploring how to make recommendations a reality. “Making more health”, a global partnership with Ashoka is focussed on identifying and supporting innovative health solutions. THE VIEW FROM THE FIELD “I have worked at BI for 12 years now and have always felt so lucky to belong to a highly desirable pharma company in the UK, it is a truly amazing place to work. You feel like you are in an adopted family where you are free to experiment and grow, challenge and create. We are all so very proud of who we are and what we do and have such fun along the way.” THE VOICE OF HR “Our efforts and energies are focused on developing our employees which is integral to the success of our business. We believe we employ exceptional people through whom we have built a culture that gives us the freedom to create excellence together.” THE VOICE OF THE SALES DIRECTOR “is is an absolutely fantastic achievement I am extremely proud that this is our sixth consecutive win. It is a real credit to everyone in our field force, our managers and all at Boehringer Ingelheim who are dedicated to putting the patient at the centre of everything we do.” Nick Doe, Sales Director 17 abcd
Transcript of NO.1 BOEHRINGER INGELHEIM - pharma field · pharma company in the UK, it is a truly amazing place...
Pf EMPLOYER OF CHOICE 2012
THERAPEUTIC SPECIALITIESCardiovascular disease, respiratory disease (COPD), diabetes, yypertension, Parkinson’s disease, HIV.
KEY PRODUCTSPradaxa, Spiriva, Trajenta, Micardis and Mirapexin, Viramune.
PIPELINE DEVELOPMENTSDiabetes, cardiometabolic diseases, central nervous system diseases, immunology, infectious diseases, oncology, respiratory.
NUMBER OF OFFICES GLOBALLY145
ANNUAL GLOBAL REVENUESEUR 12,586 million.
CONTACT DETAILSElles� eld AvenueBracknellBerkshireRG12 8YS
UK WEBSITE: www.boehringer-ingelheim.co.uk
UK CAREERS SITE:www.boehringer-ingelheim.co.uk/careers/careers.html
HR CONTACT:Tanya Mohamoodally.
NO.1 BOEHRINGER INGELHEIM
ACHIEVEMENTS IN 2011/12
Celebrated 50 years of being in the UK in May. Winners in the career representative and overall primary care category at the 2012 Pharma Times representative of the year awards. Again voted as one of the best companies to work for in the 2012 Sunday Times Top 100 ‘Best Companies’ survey rising up to 62nd place.
OVERVIEW
We are a privately owned German company with over 42,000 employees worldwide and a global vision of “Value through Innovation”. Our mission is to improve the health and wellbeing of people and animals through being part of an independent, innovative, research and development driven company.
STRENGTHS
Our culture is one of transparency and respect for the individual; we try to empower people and listen to their ideas. We also emphasise personal development and improvement, backed by excellent training.
INITIATIVES IN 2012/13
“Painting BI’s Future” a strategic review in response to the changing environment. Recommendations are now being further developed through “Implementing BI’s future” with eight cross-divisional teams exploring how to make recommendations a reality. “Making more health”, a global partnership with Ashoka is focussed on identifying and supporting innovative health solutions.
THE VIEW FROM THE FIELD
“I have worked at BI for 12 years now and have always felt so lucky to belong to a highly desirable pharma company in the UK, it is a truly amazing place to work. You feel like you are in an adopted family where you are free to experiment and grow, challenge and create. We are all so very proud of who we are and what we do and have such fun along the way.”
THE VOICE OF HR
“Our e� orts and energies are focused on developing our employees which is integral to the success of our business. We believe we employ exceptional people through whom we have built a culture that gives us the freedom to create excellence together.”
THE VOICE OF THE SALES DIRECTOR
“� is is an absolutely fantastic achievement I am extremely proud that this is our sixth consecutive win. It is a real credit to everyone in our � eld force, our managers and all at Boehringer Ingelheim who are dedicated to putting the patient at the centre of everything we do.”Nick Doe, Sales Director
17
Value through Innovation
Even after a century of experience, we remain intensely curious.
For the sake of future generations.
Boehringer Ingelheim has always remained true to its
character as an independent family-owned company.
Our vision drives us forward. It helps to foster value
through innovation in our company and to look to
the future with constantly renewed commitment
and ambition. Today we operate with 145 affiliated
companies and more than 42,000 employees worldwide.
With a track record developed over 125 years, we are
dedicated to improving the outlook for healthier lives.
www.boehringer-ingelheim.co.uk
abcd
Value through Innovation
Even after a century of experience, we remain intensely curious.
For the sake of future generations.
Boehringer Ingelheim has always remained true to its
character as an independent family-owned company.
Our vision drives us forward. It helps to foster value
through innovation in our company and to look to
the future with constantly renewed commitment and
ambition. Today, we operate globally with 142 affiliated
companies in 50 countries. With more than 41,500
employees worldwide and a track record developed
over 125 years, we are dedicated to improving the
outlook for healthier lives.
www.boehringer-ingelheim.co.uk
abcd
